Greg Curt died last Sunday. For us in oncology, this one was especially personal. He was a wonderful, generous young man. Greg was a beloved friend and colleague. He was an accomplished cancer researcher and leader in oncology who died of the disease we treat.
Alfred G. Knudson Jr., the creator of the “two-hit hypothesis,” and a director of the Institute for Cancer Research at Fox Chase Cancer Center, died July 10. He was 93.
Glenn Dalrymple, a radiology professor at the University of Nebraska Medical Center from 1990 to 1996, died March 9 in Omaha after a long battle with colon cancer. He was 81.
Michael Brattain, University of Nebraska Medical Center Eppley Institute professor and associate director for basic research in the Fred & Pamela Buffett Cancer Center, died unexpectedly in his sleep March 5. He was 68.
The Pazdurs in their garden in Bethesda, with their dog, Cleo.The dog's full name is Cleopatra, Queen of Denial.The job interview wouldn't last more than 15 minutes, Richard Pazdur believed.
Gianni Bonadonna, 81, a pioneering cancer researcher whose work focused on Hodgkin's lymphoma and breast cancer, died Sept. 7.
Cancer researcher Sidney Mirvish died at age 86. His research into nitrosamines and carcinogenesis led to changes in the way lunch meats, hot dogs and sausages were made.
Carolyn Mary Kaelin, a surgical oncologist in the Women's Cancers Program at Dana-Farber and director of the Breast Clinic at Brigham and Women's Hospital, died July 28, surrounded by loved ones. Kaelin was 54.
Wallace Ira Sampson, a longtime “quackbuster,” emeritus clinical professor of medicine at Stanford University, and former director of oncology at the Santa Clara Valley Medical Center, died May 25 following a three-month hospital stay for complications following cardiac surgery. He was 85.
The cancer field is filled with advocates—advocates for research into specific forms of malignancy, advocates for access to care for patients with limited resources, advocates for pediatric cancers—you name it. Many of these people are motivated, passionate, determined, and successful in moving their specific agendas forward in the interests of patients, clinicians, researchers, and others.